The calendar just flipped to 2024 — and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated in 2023.
X
Seven S&P 500 stocks, including Moderna (MRNA), Merck (MRK) and Eli Lilly (LLY) already gained 5% or more just this year, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSmith.
That’s an especially impressive gain in just a few days especially when you consider the major indexes’ poor start to the year. The S&P 500 is down 1.7% and Nasdaq 100 is off 3.2%, disappointing investors looking for an early year rally.
“Given the remarkable end to 2023, it’s not particularly surprising that we’re seeing a little profit-taking at this stage,” said Craig Erlam, senior market analyst at Oanda.
Turning The S&P 500 On Its Head
Some of the best stocks this early in 2024 are the ones that suffered mightily in 2023.
Vaccine maker Moderna is a great example. The maker of advanced vaccines has seen its shares already jump 9.3% this year. That makes it the top S&P 500 stock so far. Talk about a turnaround: last year Moderna stock fell 44.6%, which meant it was the fourth-worst stock in 2023.
With 2023 being a year of vaccine withdrawal, investors were ready for a not-so-great year. Moderna’s adjusted loss per share is seen swelling to $13.86 in 2023. That’s a disappointing reversal from 2022, when it made a whopping $20.12 a share. But in 2024, analysts think Moderna will only lose $6.43 a share, or roughly half of 2023’s loss. Enter optimism.
Health Care Champions
There’s no question where investors are positioning themselves for 2024. Health care is the favored industry.
Of the seven S&P 500 stocks up 5% or more this year, six (including Moderna) are in the health care sector. And it’s not just smaller S&P 500 firms. Giant Merck has seen shares shoot up 7.3% this year so far. That sure beats its 1.7% decline in 2023.
And it’s not just last year’s laggards springing back, either. Thanks to its obesity and neurological treatments, shares of Eli Lilly are up 5.4% this year. That’s on top of jumping 59.3% in 2023.
True to form, the Health Care Select Sector SPDR ETF (XLV) is up 2.1% this year. That’s the largest gain by any of the 11 S&P 500 sectors. And tech? The Technology Select Sector SPDR (XLK) is dead last with a year-to-date loss of 4.3%.
Talk about a reversal in a short period of time.
The Year Is Young
Top S&P 500 stocks in 2024 so far
| Company | Ticker | Year-to-date % ch. | Sector |
|---|---|---|---|
| Moderna | (MRNA) | 9.3% | Health Care |
| Merck | (MRK) | 7.3% | Health Care |
| Viatris | (VTRS) | 6.6% | Health Care |
| Allstate | (ALL) | 6.1% | Financials |
| Incyte | (INCY) | 6.1% | Health Care |
| Eli Lilly | (LLY) | 5.4% | Health Care |
| Amgen | (AMGN) | 5.3% | Health Care |
Follow Matt Krantz on X (Twitter) @mattkrantz
YOU MAY ALSO LIKE:
Two Of The World’s Richest Men Loaded Up On The Exact Same Stock
8 Hot Big Stocks Aren’t In The S&P 500 — But You’ll Wish They Were
Signup bonus from
